Application of efficient nanoparticles for early diagnosis and treatment of cancer

Current Drug Metabolism

Volumn 16, Issue 8, 2015, Pages 662-675

  Alexiou, Athanasios ^a   Vairaktarakis, Charalampos ^b   Tsiamis, Vasilis ^b   Ashraf, Ghulam Md ^c  

^a Ionian University   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Cancer diagnosis and treatment; Drug delivery; Gold nanoparticles; Nanomedicine; Quantum dots

Indexed keywords

GOLD NANOPARTICLE; PHOTOSENSITIZING AGENT; QUANTUM DOT; TUMOR PROTEIN; GOLD; METAL NANOPARTICLE;

ARTICLE; AUTOFLUORESCENCE; BIOCOMPATIBILITY; BREAST CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER THERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; EARLY DIAGNOSIS; EXTRACELLULAR MATRIX; FLUORESCENCE IMAGING; HUMAN; HYDROPHOBICITY; LIGHT; MACROMOLECULE; METASTASIS; MOLECULAR IMAGING; NANOENGINEERING; NANOFABRICATION; NANOTECHNOLOGY; NANOTOXICOLOGY; PANCREAS CANCER; PARTICLE SIZE; PERSONALIZED MEDICINE; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PROSTATE CANCER; PYROLYSIS; QUANTUM YIELD; SEMICONDUCTOR; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOMACH CANCER; TUMOR VASCULARIZATION; ANIMAL; EARLY CANCER DIAGNOSIS; NEOPLASMS;

ANIMALS; EARLY DETECTION OF CANCER; GOLD; HUMANS; METAL NANOPARTICLES; NEOPLASMS; QUANTUM DOTS;

EID: 84947903123     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/1389200216666150602145310     Document Type: Article

References (135)

1. Abad, E. NanoDictionary. Collegium Basilea, 2005.
2. Jabir, N. R.; Tabrez, S.; Firoz, C. K.; Zaidi, SK.; Baeesa, S. S.; Gan, S. H.; Shakil, S.; Kamal, M. A. A synopsis of nano-technological approaches toward anti-epilepsy therapy: Present and future research implications. Curr. Drug Metab., 2015, 16(5), 336-45.
3. Schmidt, M. E.; Blanton, S. A.; Hines, M. A.; Guyor-Sionnest, P. Size dependent two-photon excitation sprectroscopy of CdSe nanocrystals. Phys. Rev. B Condens. Matter, 1996, 53(19), 12629-32.
4. Peng, Z. A.; Peng, X. Formation of high-quality CdTe, CdSe, and CDS nanocrystals using CdO as precursor. J. Am. Chem. Soc., 2001, 123(1), 183-4.
5. Chan, W. C.; Nie, S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science, 1998, 281(5385), 2016-8.
6. Bruchez, M.; Moronne, M.; Gin, P.; Weiss, S.; Alivisatos, P. A. Semiconductor nanocrystals as fluorescent biological labels. Science, 1998, 281(5385), 2013-2016.
7. Mahtab, R.; Rogers, J. P.; Murphy, C. J. Protein-sized quantum-dot luminescence can distinguish between straight, bent, and kinked oligonucleotides. J. Am. Chem. Soc., 1995, 117(35), 9099-9100.
8. Akerman, M. E.; Chan, W. C.; Laakkonen, P.; Bhatia, S. N.; Ruoslahti, E. Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. USA, 2002, 99(20), 12617-21.
9. Hanaki, K.; Momo, A.; Oku, T.; Komoto, A.; Maenosono, S.; Yamaguchi, Y.; Yamamoto, K. Semiconductor quantum dot/albumin complex is a long-life and highly photostable endosome marker. Biochem. Biophys. Res. Commun., 2003, 302(3), 496-501.
10. Chen, Y. F.; Ji, T. H.; Rosenzweig, Z. Synthesis of glyconanospheres containing luminescent CdSe-ZnS quantum dots. Nano Lett., 2003, 3(5), 581-584.
11. Wu, X.; Liu, H.; Liu, J.; Haley, K. N.; Treadway, J. A.; Larson, P. J.; Ge, N. F.; Peale, F.; Bruchez, M. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol., 2003, 21, 41-46.
12. Gérard, V. A.; Maquire, C. M.; Bazou, D.; Gun'ko, Y. K. Folic acid modified gelatin coated quantum dots as potential reagents for in vitro cancer diagnostics. J. Nanobiotechnology, 2011, 9, 50.
13. Wilson, W. L.; Szajowski, P. F.; Brus, L. E. Quantum confinement in size-selected, surface-oxidized silicon nanocrystals. Science, 1993, 262(5137), 1242-1244.
14. Yu, W. W.; Qu, L. H.; Guo, W. Z.; Peng, X. G. Experimental determination of the extinction coefficient of CdTe, CdSe, and CdS nanocrystals. Chem. Mater., 2003, 15(14), 2854-60.
15. Kim, S. W.; Zimmer, J. P.; Ohnishi, S.; Tracy, J. B.; Frangioni, J. V.; Bawendi, M. G. Engineering InAsxP1-x/InP/ZnSe III-V alloyed core/shell quantum dots for the near-infrared. Chem. Soc., 2005, 127(30), 10526-32.
16. Norris, D. J.; Efros, A. L.; Rosen, N.; Bawendi, M. G. Size dependence of exciton fine structure in CdSe quantum dots. Phys. Rev. B Condens. Matter, 1996, 53(24), 16347-16354.
17. Peng, X.; Manna, L.; Yang, W.; Wickham, J.; Scher, E.; Kadavanich, A.; Alivisatos, A. P. Shape control of CdSe nanocrystals. Nature, 2000, 404(6773), 59-61.
18. Qu, L.; Peng, Z. A.; Peng, X. Alternative routes toward high quality CdSe nanocrystals. Nanoletters, 2001, 1(6), 333-337.
19. Gao, B.; Shen, C.; Yuan, S.; Zhang, B.; Zhang, M.; Yang, Y. Influence of nanocrystals size on the quantum dots sensitized solar cells' performance with low temperature synthesized CdSe quantum dots. J. Alloys Compd., 2014, 612, 323-329.
20. Dabbousi, B. O.; Rodriguez, V. J.; Mikulec, F. V.; Heine, J. R.; Mattoussi, H.; Ober, R.; Jensen, K. F., Bawendi, M. G. (CdSe) ZnS coreshell quantum dots: Synthesis and characterization of a size series of highly luminescent nanocrystallites. J. Phys. Chem. B, 1997, 101(46), 9463-9475.
21. Hines, M. A.; Guyot-Sionnest, P. Synthesis and characterization of strongly luminescing ZnS-capped CdSe nanocrystals. J. Phys. Chem., 1996, 100(2), 468-471.
22. Peng, X.; Schlamp, M. C.; Kadavanich, A. V.; Alivisatos, A. P. Epitaxial growth of highly luminescent CdSe/CdS core/shell nanocrystals with photostability and electronic accessibility. J. Am. Chem. Soc., 1997, 119(30), 7019-7029.
23. Chu, M.; Pan, X.; Zhang, D.; Wu, Q.; Peng, J.; Hai, W. The therapeutic efficacy of CdTe and CdSe quantum dots ofr photothermal cancer therapy. Biomaterials, 2012, 33(29), 7071-83.
24. Delehanty, J. B.; Medintz, I. L.; Pons, T.; Dawson, P. E.; Brunel, F. M.; Mattoussi, H. Self-assembled quantum dot-deptide bioconjugates for selective intracellular delivery. Bioconjug. Chem., 2006, 17(4), 920-927.
25. Jain, R. K. Transport molecules, particles, and cells in solid tumors. Annu. Rev. Biomed. Eng., 1999, 1, 241-63.
26. Jain, R. K. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J. Control. Release, 2001, 74(1-3), 7-25.
27. Gao, X.; Cui, Y.; Levenson, R. M.; Chung, L. W.; Nie, S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol., 2004, 22(8), 969-76.
28. Voura, E. B.; Jaiswal, J. K.; Mattoussi, H.; Simon, S. M. Traching metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat. Med., 2004, 10(9), 993-8.
29. Yong, K. T.; Ding, H.; Roy, I.; Law, W. C.; Bergey, E. J.; Maitra, A.; Prasad, P. N. Imaging pancreatic cancer using bioconjugated InP quantum dots. ACS Nano, 2009, 3(3), 502-510.
30. Peng, C. W.; Tian, Q.; Yang, G. F.; Fang, N.; Zhang, Z. L.; Peng, J.; Li, Y.; Pang, D. W. Quantum-dots based simultaneous detection of multiple biomarkers of tumor stromal features to predict clinical outcomes in gastric cancer. Biomaterials, 2012, 33(23), 5742-52.
31. Bostick, R. M.; Kong, K. Y.; Ahearn, T. U.; Chaudry, Q.; Cohen, V.; Wang, M. D. Detecting and quantifying biomarkers of risk for colorectal cancer using quantum dots and novel image analysis algorithms. Conf. Proc. IEEE Eng. Med. Biol. Soc., 2006, 1, 3313-6.
32. Slamon, D. J.; Godolphin, W.; Jones, L. A.; Holt, J. A.; Wong, S. G.; Keith, D. E.; Levin, W. J.; Stuart, S. G.; Udove, J.; Ullrich, A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 1989, 244(4905), 707-12.
33. Yezhelyev, M. V.; Al-Hajj, A.; Morris, C.; Marcus, A. I.; Liu, T.; Lewis, M.; Cohen, C.; Zrazhevskiy, P.; Simons, J. W.; Rogatko, A.; Nie, S.; Gao, X.; O'Regan, R. M. In situ molecular profiling of breast cancer biomarkers with multicolor quantum dots. Adv. Mater., 2007, 19(20), 3146-51.
34. Zhang, H.; Sachdev, D.; Wang, C.; Hubel, A.; Gaillard-Kelly, M.; Yee, D. Detection and downregulation of type I IGF receptor ex pression by antibody-conjugated quantum dots in breast cancer cells. Breast Cancer Res. Treat., 2009, 114(2), 227-85.
35. Chen, C.; Peng, J.; Xia, H. S.; Yang, G. F.; Wu, Q. S.; Chen, L. D.; Zeng, L. B.; Zhang, Z. L.; Pang, D. W.; Li, Y. Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer. Biomaterials, 2009, 30(15), 2912-8.
36. Liu, X. L.; Peng, C. W.; Chen, C.; Yang, X. Q.; Hu, M. B.; Xia, H. S.; Liu, S. P.; Pang, D. W.; Li, Y. Quantum dots-based double-color imaging of HER2 positive breast cancer invasion. Biochem. Biophys. Res. Commun., 2011, 409(3), 577-82.
37. Cai, W.; Shin, D. W.; Chen, K.; Gheysens, O.; Cao, Q.; Wang, S. X.; Gambhir, S. S.; Chen, X. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett., 2006, 6(4), 669-76.
38. Geszke, M.; Murias, M.; Balan, L.; Medjahdi, G.; Korczynski, J.; Moritz, M.; Lulek, J.; Schneider, R. Folic acid-conjugated core/cell ZnS:Mn/ZnS quantum dots as targeted probes for two photon fluorescence imaging of cancer cells. Acta Biomater., 2011, 7(3), 1327-38.
39. Chang, S. S.; Reuter, V. E.; Heston, W. D.; Gaudin, P. B. Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen. Urology, 2001, 57(4), 801-5.
40. Schülke, N.; Varlamova, O. A.; Donovan, G. P.; Ma, D.; Gardner, J. P.; Morrissey, D. M.; Arrigale, R. R.; Zhan, C.; Chodera, A. J.; Surowitz, K. G.; Maddon, P. J.; Heston, W. D.; Olson, W. C. The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy. Proc. Natl. Acad. Sci. USA, 2003, 100(22), 12590-5.
41. Bagalkot, V.; Zhang, L.; Levy-Nissenbaum, E.; Jon, S.; Kantoff, P. W.; Langer, R.; Farokhzad, O. C. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on by-fluorescence resonance energy transfer. Nano Lett., 2007, 7(10), 3065-70.
42. Argani, P.; Iacobuzio-Donahue, C.; Ryu, B.; Rosty, C.; Goggins, M.; Wilentz, R. E.; Murugesan, S. R.; Leach, S. D.; Jaffee, E.; Yeo, C. J.; Cameron, J. L.; Kern, S. E.; Hruban, R. H. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin. Cancer Res., 2001, 7(12), 3862-8.
43. Lee, K. H.; Galloway, J. F.; Park, J.; Dvoracek, C. M.; Dallas, M.; Konstantopoulos, K.; Maitra, A.; Searson, P. C. Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots. Nanomedicine, 2012, 8(7), 1043-51.
44. Zurrida, S.; Morabito, A.; Galimberti, V.; Luini, A.; Graco, M.; Bartoli, C.; Raselli, R.; Rossi, N.; Vessecchia, G.; Cascinelli, N.; Veronesi, U. Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer. Int. J. Oncol., 1999, 15(3), 475-80.
45. Ballou, B.; Lagerholm, B. C.; Ernst, L. A.; Bruckez, M. P.; Waggoner, A. S. Noninvasive imaging of quantum dots in mice. Bioconjug. Chem., 2004, 15(1), 79-86.
46. Larson, D. R.; Zipfel, W. R.; Williams, R. M.; Clark, S. W.; Bruchez, M. P.; Wise, F. W.; Webb, W. W. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science, 2003, 300(5624), 1434-6.
47. Uren, R. F.; Howman-Giles, R.; Thompson, J. F. Patterns of lymphatic drainage from the skin in patients with melanoma. J. Nucl. Med., 2003, 44(4), 570-82.
48. Zimmer, J. P.; Kim, S. W.; Ohnishi, S.; Tanaka, E.; Frangioni, J. V.; Bawendi, M. G. Size series of small indium arsenide-zinc selenide core-shell nanocrystals and their application to in vivo imaging. J. Am. Chem. Soc., 2006, 128(8), 2526-7.
49. Soltesz, E. G.; Kim, S.; Laurence, R. G.; DeGrand, A. M.; Parungo, C. P.; Dor, D. M.; Cohn, L. H.; Bawendi, M. G.; Frangioni, J. V.; Mihaljevic, T. Intraoperative sentinel lymph node mapping of the ling using near-infrared fluorescent quantum dots. Ann. Thorac. Surg., 2005, 79(1), 269-77.
50. Si, C.; Zhang, Y.; Lv, X.; Yang, W.; Ran, Z.; Sun, P. In vivo lymph node mapping by Cadmium Tellurium quantum dots in rats. J. Surg. Res., 2014, 192(2), 305-11.
51. Li, C.; Zhang, Y.; Wang, M.; Zhang, Y.; Chen, G.; Li, L.; Wu, D.; Wang, Q. In vivo real-time visualization of tissue blood flow and angiogenesis using Ag2S quantum dots in the NIR-II window. Biomaterials, 2014, 35(1), 393-400.
52. Gao, X.; Cui, Y.; Levenson, R. M.; Chung, L. W.; Nie, S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol., 2004, 22(8), 969-76.
53. Yu, X.; Chen, L.; Li, K.; Li, Y.; Xiao, S.; Luo, X.; Liu, J.; Zhou, L.; Deng, Y.; Pang, D.; Wang, Q. Immunofluorescence detection with quantum dot bioconjugates for hepatoma in vivo. J. Biomed. Opt., 2007, 12(1), 014008.
54. Kim, S.; Lim, Y. T.; Soltesz, E. G.; De Grand, A. M.; Lee, J.; Nakayama, A.; Parker, J. A.; Mihaljevic, T.; Laurence, R. G.; Dor, D. M.; Cohn, L. H.; Bawendi, M. G.; Frangioni, J. V. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol., 2004, 22(1), 93-7.
55. Shi, C.; Zhu, Y.; Xie, Z.; Qian, W.; Hsieh, C. L.; Nie, S.; Su, Y.; Zhau, H. E.; Chung, L. W. Visualizing human prostate cancer cells in mouse skeleton using bioconjugated near-infrared fluorescent quantum dots. Urology, 2009, 74(2), 446-51.
56. Yang, K.; Cao, Y. A.; Shi, C.; Li, Z. G.; Zhang, F. J.; Yang, J.; Zhao, C. Quantum dot-based visual in vivo imaging for oral squamous cell carcinoma in mice. Oral Oncol., 2010, 46(12), 864-8.
57. Ma, Q.; Nakane, Y.; Mori, Y.; Hasegawa, M.; Yoshioka, Y.; Watanabe, T. M.; Gonda, K.; Ohuchim N.; Jin, T. Multilayered, core/shell nanoprobes based on magnetic ferric oxide particles and quantum dots for multimodality imaging of breast cancer tumors. Biomaterials, 2012, 33(33), 8486-94.
58. Derfus, A. M.; Chan, W. C. W.; Bhatia, S. N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett., 2004, 4(1), 11-18.
59. Yang, R. S.; Chang, L. W.; Wu, J. P.; Tsai, M. H.; Wang, H. J.; Kuo, Y. C.; Yeh, T. K.; Yang, C. S.; Lin, P. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ. Health Perspect., 2007, 115(9), 1339-43.
60. Kirchner, C.; Liedl, T.; Kudera, S.; Pellegrino, T.; Muñoz Javier, A.; Gaub, H. E.; Stölzle, S.; Fertig, N.; Parak, W. J. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett., 2005, 5(2), 331-8.
61. Cho, S. J.; Maysinger, D.; Jain, M.; Röder, B.; Hackbarth, S.; Winnik, F. M. Long-term exposure to CdTe quantum dots causes functional impairments in live cells. Langmuir, 2007, 23(4), 1974-80.
62. Stern, S. T.; Zolnik, B. S.; McLeland, C. B.; Clogston, J.; Zheng, J.; McNeil, S. E. Induction of autophagy in porcine kidney cells by quantum dots: a common cellular response to nanomaterials? Toxicol. Sci., 2008, 106(1), 140-52.
63. Tang, Y.; Han, S.; Liu, H.; Chen, X.; Huang, L.; Li, X.; Zhang, J. The role of surface chemistry in determining in vivo biodistribution and toxicity of CdSe/ZnS core-shell quantum dots. Biomaterials, 2013, 34(34), 8741-55.
64. Liu, T.; Xing, R.; Zhou, Y. F.; Zhang, J.; Su, Y. Y.; Zhang, K. Q.; He, Y.; Sima, Y. H.; Xu, S. Q. Hematopoiesis toxicity induced by CdTe quantum dots determined in an invertebrate model organism. Biomaterials, 2014, 35(9), 2942-51.
65. Samia, A. C.; Chen, X.; Burda, C. Semiconductor quantum dots for photodynamic therapy. J. Am. Chem. Soc., 2003, 125(51), 15736-7.
66. Ma, J.; Chen, J. Y.; Idowu, M.; Nyokong, T. Generation of singlet oxygen via the composites of water-soluble thiol-capped CdTe quantum dots-sulfonated aluminum phthalocyanines. J. Phys. Chem. B, 2008, 112(15), 4465-9.
67. Clarke, S. J.; Hollmann, C. A.; Zhang, Z.; Suffern, D.; Bradforth, S. E.; Dimitrijevic, N. M.; Minarik, W. D.; Nadeau, J. L. Photophysics of dopamine-modified quantum dots and effects on biological systems. Nat. Mater., 2006, 5(5), 409-17.
68. Tsay, J. M.; Trzoss, M.; Shi, L.; Kong, X.; Selke, M.; Jung, M. E.; Weiss, S. Singlet oxygen production by peptide-coated quantum dot-photosensitizer conjugates. J. Am. Chem. Soc., 2007, 129(21), 6865-71.
69. Dayal, S.; Burda, C. Surface effects on quantum dot-based energy transfer. J. Am. Chem. Soc., 2007, 129(25), 7977-81.
70. Shi, L.; Hernander, B.; Selke, M. Singlet oxygen generation from water-soluble quantum dot-organic dye nanocomposites. J. Am. Chem. Soc., 2006, 128(19), 6278-9.
71. Duong, H. D.; Rhee, J. I. Singlet oxygen production by fluorescence resonance energy transfer (FRET) from green and orange CdSe/ZnS QDs to protoporphyrin IX (PpIX). Chem. Phys. Lett., 2011, 501(4-6), 496-501.
72. Hsu, C. Y.; Chen, C. W.; Yu, H. P.; Lin, Y. F.; Lai, P. S. Bioluminescence resonance energy transfer using luciferase-immobilized quantum dots for self-illuminated photodynamic therapy. Biomaterials, 2013, 34(4), 1204-12.
73. Liu, Y.; Mi, Y.; Zhao, J; Feng, S. S. Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agents. Int. J. Pharm., 2011, 421(2), 370-8.
74. Weng, K. C.; Noble, C. O.; Papahadjopoulos-Sternberg, B.; Chen, F. F.; Drummond, D. C.; Kirpotin, D. B.; Wang, D.; Hom, Y. K.; Hann, B.; Park, J. W. Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo. Nano Lett., 2008, 8(9), 2851-7.
75. Bagalkot, V.; Zhang, L.; Levy-Nissenbaum, E.; Kantoff, P. W.; Langer, R.; Farokhzad, O. C. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on by-fluorescence resonance energy transfer. Nano Lett., 2007, 7(10), 3065-70.
76. Savla, R.; Taratula, O.; Garbuzenko, O.; Minko, T. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J. Control. Release, 2011, 153(1), 16-22.
77. Chen, T.; Zhao, T.; Wei, D.; Wei, Y.; Li, Y; Zhang, H. Core-shell nanocarriers with ZnO quantum dots-conjugated Au nanoparticles for tumor-targeted drug delivery. Carbohybr. Polym., 2013, 92(2), 1124-32.
78. Fricker, S. P.; Buckley, R. G. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents. Anticancer Res., 1996, 16(6B), 3755-60.
79. Faraji, A. H.; Wipf, P. Nanoparticles in cellular drug delivery. Bioorg. Med. Chem., 2009, 17(8), 2950-62.
80. Anker, J. N.; Hall, W. P.; Lyandres, O.; Shah, N. C.; Zhao, J.; Van Duyne, R. P. Biosensing with plasmonic nanosensors. Nat. Mater., 2008, 7(6), 442-53.
81. Chen, H.; Roco, M. C.; Li, X.; Lin, Y. Trends in nanotechnology patents. Nat. Nanotechnol., 2008, 3(3), 123-5.
82. Patra, C. R.; Bhattacharya, R.; Wang, E.; Katarya, A.; Lau, J. S.; Dutta, S.; Muders, M.; Wang, S.; Buhrow, S. A.; Safgren, S. L.; Yaszemski, M. J.; Reid, J. M.; Ames, M. M.; Kukherjee, P.; Mukhopadhyay, D. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res., 2008, 68(6), 1970-8.
83. Patra, C. R.; Bhattacharya, R.; Mukhopadhyay, D.; Mukherjee, P. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv. Drug Deliv. Rev., 2010, 62(3), 346-61.
84. Huang, X.; El-Sayed, M. A. Gold nanoparticles: Optical properties and implementations in cancer diagnosis and photothermal therapy. J. Adv. Res., 2010, 1(1), 13-28.
85. Eustis, S.; El-Sayed, M. A. Why gold nanoparticles are more precious than pretty gold: noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystal of different shapes. Chem. Soc. Rev., 2006, 35(3), 209-17.
86. Jain, P. K.; Lee, K. S.; El-Sayed, I. H.; El-Sayed, M. A. Calculated absorption and scattering properties of gold nanoparticles of different size, shape and composition: applications in biological imaging and biomedicine. J. Phys. Chem. B, 2006, 110(14), 7238-48.
87. Stober, W.; Fink, A.; Bohn, E. Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci., 1968, 28, 62-9.
88. Brongersma, M. L. Nanoscale photonics: Nanoshells: gifts in a gold wrapper. Nat. Mater., 2003, 2(5), 296-7.
89. Link, S.; El-Sayed, M. A. Optical properties and ultrafast dynamics of metallic nanocrystals. Annu. Rev. Phys. Chem., 2003, 54, 331-66.
90. El-Sayed, M. A. Some interesting properties of metals confined in time and nanometer space of different shapes. Acc. Chem. Res., 2001, 34(4), 257-64.
91. Bhattacharyya, S.; Kudgus, R. A.; Bhattacharya, R.; Mukherjee, P. Inorganic nanoparticles in cancer therapy. Pharm. Res., 2011, 28(2), 237-59.
92. Hainfeld, J. F.; Slatkin, D. N.; Focella, T. M.; Smilowitz, H. M. Gold nanoparticles: a new X-ray contrast agent. Br. J. Radiol., 2006, 79(939), 248-53.
93. Murphy, C. J.; Gole, A. M.; Stone, J. W.; Sisco, P. N.; Alkilany, A. M.; Goldsmith, E. C.; Baxter, S. C. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc. Chem. Res., 2008, 41(12), 1721-30.
94. Pan, Y.; Neuss, S.; Leifert, A.; Fischler, M.; Wen, F.; Simon, U.; Schmid, G.; Brandau, W.; Jahnen-Dechent, W. Size-dependent cytotoxicity of gold nanoparticles. Small, 2007, 3(11), 1941-9.
95. Kattumuri, V.; Katti, K.; Bhaskaran, S.; Boote, E. J.; Casteel, S. W.; Fent, G. M.; Robertson, D. J.; Chandrasekhar, M.; Kannan, R.; Katti, K. V. Gum Arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrastimaging studies. Small, 2007, 3(2), 333-41.
96. Lee, k.; Lee, H.; Bae, K. H.; Park, T. G. Heparin immobilizedgold nanoparticles for targeted detection and apoptotic death of metastatic cancer cells. Biomaterials, 2010, 31(25), 6530-6.
97. Orendorff, C. J.; Sau, T. K.; Murphy, C. J. Shape-dependent plasmonresonant gold nanoparticles. Small, 2006, 2(5), 636-9.
98. Huang, X.; El-Sayed, I. H.; Qian, W.; El-Sayed, M. A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc., 2006, 128(6), 2115-20.
99. Sokolov, K.; Follen, M.; Aaron, J.; Pavlova, I.; Malpica, A.; Lotan, R.; Richards-Kortum, R. Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res., 2003, 63(9), 1999-2004.
100. Sokolov, K.; Aaron, J.; Hsu, B.; Nida, D.; Gillenwater, A.; Follen, M.; MacAulay, C.; Adler-Storthz, K.; Korgel, B.; Descour, M.; Pasqualini, R.; Arap, W.; Lam, W.; Richards-Kortum, R. Optical systems for in vivo molecular imaging of cancer. Technol. Cancer Res. Treat., 2003, 2(6), 491-504.
101. Loo, C.; Lin, A.; Hirsch, L.; Lee, M. H.; Barton, J.; Halas, N.; West, J.; Drezek, R. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol. Cancer Res. Theat., 2004, 3(1), 33-40.
102. El-Sayed, I. H.; Huang, X.; El-Sayed, M. A. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett., 2005, 5(5), 829-34.
103. Alexiou, A.; Vlamos, P. Ethics at the crossroads of bioinformatics and nanotechnology. 8th International Conference of Computer Ethics & Philosophical Enquiry (CEPE), 2009.
104. Kim, D.; Jon, S. Gold nanoparticles in image-guided cancer therapy. Inorganica Chimica Acta, 2012, 393, 154-164.
105. Ai, J.; Xu, Y.; Lou, B.; Li, D.; Wang, E. Multifunctional AS1411-functionalized fluorescent gold nanoparticles for targeted cancer cell imaging and efficient photodynamic therapy. Talanta, 2014, 118, 54-60.
106. Kumar, A.; Ma, H.; Zhang, X.; Huang, K.; Jin, S.; Liu, J.; Wei, T.; Cao, W.; Zou, G.; Liang, X. J. Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment. Biomaterials, 2012, 33(4), 1180-9.
107. Jing, L.; Liang, X.; Deng, Z.; Feng, S.; Li, X.; Huang, M.; Li, C.; Dai, Z. Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer. Biomaterials, 2014, 35(22), 5814-21.
108. Nossier, A. I.; Eissa, S.; Ismael, M. F.; Hamdy, M. A.; Azzazy, H. M. Direct detection of hyaluronidase in urine using cationic gold nanoparticles: a potential diagnostic test for bladder cancer. Biosens. Bioelectron., 2014, 54, 7-14.
109. Sharma, P.; Brown, S.; Walter, G.; Santra, S.; Moudgil B. Nanoparticles for bioimaging. Adv. Colloid Interface Sci., 2006, 123-126, 471-85.
110. Mahmood, J.; Weissleder, R. Some tools for molecular imaging. Acad. Radiol., 2002, 9, 629-631.
111. Cheon, J.; Lee, J. H. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc. Chem. Res., 2008, 41(12), 1630-40.
112. Lima, K. M. G.; Araujo Junior, R. F.; Araujo, A. A.; Oliveira, A. L. C. S. L.; Gasparotto, L. H. S. Environmentally compatible bioconjugated gold nanoparticles as efficient contrast agents for colorectal cancer cell imaging. Sens. Actuator B-Chem., 2014, 196, 306-313.
113. Kim, C. S.; Ahn, Y. C.; Wilder-Smith, P.; Oh, S.; Chen, Z.; Jik, Y. Efficient and facile delivery of gold nanoparticles in vivo using dissolvable microneedles for contrast-enhanced optical coherence tomography. Biomed. Opt. Express, 2010, 1(1), 106-113.
114. Kelly, K. L.; Coronado, E.; Zhao, L. L.; Schatz, G. C. The optical properties of metal nanoparticles: The influence of size, shape, and dielectric environment. J. Phys. Chem., 2003, 107(3), 668-677.
115. Maksimova, I. L.; Akchurin, G. G.; Khlebtsov, B. N.; Terentyuk, G. S.; Akchurin, G. G.; Ermolaev, I. A.; Skaptsov, A. A.; Soboleva, E. P.; Khlebtsov, N. G.; Tuchin, V. V. Near-infrared laser photothermal therapy of cancer by using gold nanoparticles: Computer simulations and experiment. Med. Laser Appl., 2007, 22(3), 199-206.
116. Kuo, W. S.; Chang, C. N.; Chang, Y. T.; Yang, M. H.; Chien, Y. H.; Chen, S. J.; Yeh, C. S. Gold nanorods in photodynamic therapy, as hyperthermia agents, and in near-infrared optical imaging. Angew Chem. Int. Ed. Engl., 2010, 49(15), 2711-5.
117. Huang, X.; El-Sayed, I. H.; Qian, W.; El-Sayed, M. A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold naorods. J. Am. Chem. Soc., 2006, 128(6), 2115-20.
118. Chen, J.; Wang, D.; Xi, J.; Au, L.; Siekkinen, A.; Warsen, A.; Li, Z. Y.; Zhang, H.; Xia, Y.; Li, X. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett., 2007, 7(5), 1318-22.
119. Au, L.; Zheng, D.; Zhou, F.; Li, Z. Y.; Li, X.; Xia, Y. A quantitative study on the photothermal effect of immune gold nanocages targeted to breast cancer cells. ACS Nano, 2008, 2(8), 1645-52.
120. Chen, J.; Glaus, C.; Laforest, R.; Zhang, Q.; Yang, M.; Gidding, M.; Welch, M. J.; Xia, Y. Gold nanocages as photothermal transducers for cancer treatment. Small, 2010, 6(7), 811-7.
121. Murawala, P.; Tirmale, A.; Shiras, A.; Prasad, B. L. In situ synthesized BSA capped gold nanoparticles: effective carrier of anticancer drug methotrexate to MCF-7 breast cancer cells. Mater. Sci. Eng. C Mater. Biol. Appl., 2014, 34, 158-67.
122. Cheng, Y.; C Samia, A.; Meyers, J. D.; Panagopoulos, I.; Fei, B.; Burda, C. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J. Am. Chem. Soc., 2008, 130(32), 10643-7.
123. Vankayala, R.; Lin, C. C.; Kalluru, P.; Chiang, C. S.; Hwang, K. C. Gold nanoshells-mediated bimodal photodynamic and photothermal cancer treatment using ultra-low doses of near infra-red light. Biomaterials, 2014, 35(21), 5527-38.
124. Parzko, E.; Ehrhardt, C.; Senge, M. O.; Kelleher, D. P.; Reynolds, J. V. Nanodrug applications in photodynamic therapy. Photodiagnosis Photodyn. Ther., 2011, 8(1), 14-29.
125. Vankayala, R.; Sagadevan, A.; Vijayaraqhavan, P.; Kuo, C. L.; Hwang, K. C. Metal nanoparticles sensitize the formation of singlet oxygen. Angew Chem. Int. Ed. Engl., 2011, 50(45), 10640-4.
126. Huang, P.; Lin, J.; Wang, S.; Zhou, Z.; Li, Z.; Wang, Z.; Zhang, C.; Yue, X.; Niu, G.; Yang, M.; Cui, D.; Chen, X. Photosensitizerconjugated silica-coated gold nanoclusters for fluorescence imagingguided photodynamic therapy. Biomaterials, 2013, 34(19), 4643-54.
127. Rosi, N. L.; Mirkin, C. A. Nanostructures in biodiagnostics. Chem. Rev., 2005, 105(4), 1547-62.
128. Whitesides, G. M. The 'right' size in nanobiotechnology. Nat. Biotechnol., 2003, 21(10), 1161-5.
129. Link, S.; El-Sayed, M. A. Optical properties and ultrafast dynamics of metallic nanocrystals. Annu. Rev. Phys. Chem., 2003, 54, 331-66.
130. Jabir, N. R.; Tabrez, S.; Ashraf, G. M.; Shakil, S.; Damanhouri, G. A.; Kamal, M. A. Nanotechnology-based approaches in anticancer research. Int. J. Nanomedicine, 2012, 7, 4391-408.
131. Tabrez, S.; Priyadarshini, M.; Urooj, M.; Shakil, S.; Ashraf, G. M; Khan, M. S.; Kamal, M. A.; Alam, Q.; Jabir, N. R.; Abuzenadah, A. M.; Chaudhary, A. G.; Damanhouri, G. A. Cancer chemoprevention by polyphenols and their potential application as nanomedicine. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev., 2013, 31(1), 67-98.
132. Ali, R.; Mirza, Z.; Ashraf, G. M.; Kamal, M. A.; Ansari, S. A.; Damanhouri, G. A.; Abuzenadah, A. M.; Chaudhary, A. G.; Sheikh, I. A. New anticancer agents: recent developments in tumor therapy. Anticancer Res., 2012, 32(7), 2999-3005.
133. Haranas, I.; Gkigkitzis, I.; Alexiou, A. Fractal growth on the surface of a planet and in orbit around it. Microgravity Sci. Technol., 2014, 26(5), 313-325.
134. Alexiou A, Psiha M, Vlamos P. Ethical Issues of Artificial Biomedical Applications. 8th Artificial Intelligence Applications & Innovations, H. Papadopoulos et al. (Eds.) EANN/AIAI 2011, Part II. IFIP AICT, vol. 364, pp. 297-302, © IFIP International Federation for Information Processing 2011, Springer, Heidelberg.
135. Alexiou A, Theocharopoulou Georgia, Vlamos P. Ethical Issues in Neuroinformatics. 9th Artificial Intelligence Applications and Innovations Conference, 1st Workshop on Ethics and Philosophy in Artificial Intelligence, H. Papadopoulos et al. (Eds.): AIAI 2013, IFIP AICT 364, pp. 297-302, 2013, © IFIP International Federation for Information Processing 2013, Springer, Heidelberg.